These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2723134)

  • 41. [Balance-sheet after 5-years of beta-blocker use in psychiatry. General considerations on beta-active substances].
    Scharbach H
    Ann Med Psychol (Paris); 1977 Apr; 1(4):600-15. PubMed ID: 23717
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparative study using double-blind method of sultopride and thioproperazine].
    Sizaret P; Moreau C
    Encephale; 1977; 3(2):111-20. PubMed ID: 19230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study.
    Nygaard H; Bakke K; Brudvik E; Lien GK; Moe TJ; Elgen K
    Pharmatherapeutica; 1988; 5(3):152-8. PubMed ID: 2896359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A theoretical examination of double-blind design.
    Hoffer A
    Can Med Assoc J; 1967 Jul; 97(3):123-7. PubMed ID: 5339046
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of sodium valproate in violent and aggressive behaviors: a critical review.
    Lindenmayer JP; Kotsaftis A
    J Clin Psychiatry; 2000 Feb; 61(2):123-8. PubMed ID: 10732659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The clinical significance of halopemide, a dopamine-blocker related to the butyrophenones.
    De Cuyper H; van Praag HM; Verstraeten D
    Neuropsychobiology; 1984; 12(4):211-6. PubMed ID: 6398861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blinding effectiveness and association of pretreatment expectations with pain improvement in a double-blind randomized controlled trial.
    Turner JA; Jensen MP; Warms CA; Cardenas DD
    Pain; 2002 Sep; 99(1-2):91-9. PubMed ID: 12237187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder.
    Westenberg HG; den Boer JA
    Psychopharmacol Bull; 1989; 25(1):119-23. PubMed ID: 2528158
    [No Abstract]   [Full Text] [Related]  

  • 49. Methods and models for placebo use in pharmacotherapeutic trials.
    Prien RF
    Psychopharmacol Bull; 1988; 24(1):4-8. PubMed ID: 3290947
    [No Abstract]   [Full Text] [Related]  

  • 50. Without double blind randomization, what can we conclude?
    Elashoff JD
    Dig Dis Sci; 1980 Dec; 25(12):972-3. PubMed ID: 6893816
    [No Abstract]   [Full Text] [Related]  

  • 51. Use of lithium in children and adolescents.
    Campbell M; Perry R; Green WH
    Psychosomatics; 1984 Feb; 25(2):95-101, 105-6. PubMed ID: 6422487
    [No Abstract]   [Full Text] [Related]  

  • 52. Lorazepam vs. alprazolam in the treatment of panic disorder.
    Schweizer E; Pohl R; Balon R; Fox I; Rickels K; Yeragani VK
    Pharmacopsychiatry; 1990 Mar; 23(2):90-3. PubMed ID: 2187213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical trials. Controlled or double blind?
    Bridges-Webb C
    Aust Fam Physician; 1984 Sep; 13(9):680. PubMed ID: 6508650
    [No Abstract]   [Full Text] [Related]  

  • 54. There are no alternatives to double-blind, controlled trials.
    Noseworthy JH
    Neurology; 1988 Jul; 38(7 Suppl 2):76-9. PubMed ID: 3290719
    [No Abstract]   [Full Text] [Related]  

  • 55. Consumer satisfaction with involvement in drug research: a social validity study.
    Aman MG; Wolford PL
    J Am Acad Child Adolesc Psychiatry; 1995 Jul; 34(7):940-5. PubMed ID: 7649965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychotropic medication with children: an evaluation of procedural biases in results of reported studies.
    Sulzbacher SI
    Pediatrics; 1973 Mar; 51(3):513-7. PubMed ID: 4575105
    [No Abstract]   [Full Text] [Related]  

  • 57. The sequential parallel comparison model: a revolution in the design of clinical trials.
    Grandi S
    Psychother Psychosom; 2003; 72(3):113-4. PubMed ID: 12707477
    [No Abstract]   [Full Text] [Related]  

  • 58. Characterizing onset in psychopharmacological clinical trials.
    Laska EM; Siegel C
    Psychopharmacol Bull; 1995; 31(1):29-35. PubMed ID: 7675985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Double-blinding in clinical trials.
    Ney PG
    CMAJ; 1989 Jan; 140(1):15. PubMed ID: 2909265
    [No Abstract]   [Full Text] [Related]  

  • 60. [First application of tablet form bromperidol in man with particular consideration of tolerance].
    Pöldinger W; Bures E
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():26-9. PubMed ID: 35474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.